Featured

Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP

Do Accelerated Approvals Really Benefit Patients? With Ravi Parikh, MD, MPP

Recently, Ravi Parikh, MD, MPP, an Assistant Professor of Medical Ethics and Health Policy and Medicine at the University of Pennsylvania, Perelman School of Medicine, released a research letter titled, "Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval." In this interview with OncData, he further discusses his research and gives a thought-provoking analysis of what these findings could mean for the future of the accelerated approval program, as well as how the multidisciplinary team could better advocate and let their voices ...

From the Editor's Desk

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD

I am thrilled to announce that I will be staying on as Editor in Chief of Oncology Data Advisor for at least another year. It gives me such great joy to work with such an accomplished group of experts in oncology, as well as with an extremely professional core of editors headed up by Keira Smith. We have grand plans for 2023. In the meantime, please avail yourselves of some of the best commentary in oncology today. I want to especially recommend two of our offerings that have recently hit the we...

Expert Analysis

Rare Disease Day With Thomas Abrams, MD; Maria Badillo, MSN, RN, OCN®, CCRP; and Ulka Vaishampayan, MD

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD

Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD

Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

Practice Patterns

Knowledge Gains for Immunotherapeutic Strategies in Cervical Cancer

Knowledge Gains for Immunotherapeutic Strategies in Cervical Cancer

Educational Advancements Made in Treatment of Merkel Cell Carcinoma

Educational Advancements Made in Treatment of Merkel Cell Carcinoma

Enhancing Treatment and Patient-Care Proficiency in Multiple Myeloma

Enhancing Treatment and Patient-Care Proficiency in Multiple Myeloma

Noteworthy Headlines

Dabrafenib Plus Trametinib Approved for Pediatric BRAF V600E–Mutated Low-Grade Glioma

Dabrafenib Plus Trametinib Approved for Pediatric BRAF V600E–Mutated Low-Grade Glioma

Abemaciclib With Endocrine Therapy Receives Expanded Approval for Early Breast Cancer

Abemaciclib With Endocrine Therapy Receives Expanded Approval for Early Breast Cancer

Dostarlimab-gxly Approved For dMMR Endometrial Cancer

Dostarlimab-gxly Approved For dMMR Endometrial Cancer

Sacituzumab Govitecan-hziy Approved for HR-Positive Breast Cancer

Sacituzumab Govitecan-hziy Approved for HR-Positive Breast Cancer

Elacestrant Approved for ER-Positive, HER2-Negative, ESR1-Mutated Breast Cancer

Elacestrant Approved for ER-Positive, HER2-Negative, ESR1-Mutated Breast Cancer

Most Popular

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD

Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD

Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD

How to Counsel Genitourinary Cancer Patients About COVID-19 Vaccine Safety With Hyma Polimera, MD

Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

Podcast Spotlight

Rare Disease Day With Thomas Abrams, MD; Maria Badillo, MSN, RN, OCN®, CCRP; and Ulka Vaishampayan, MD

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Ticiana Leal, MD

Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD

Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD

Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD

Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD

Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials With Shernan Holtan, MD

Additional Advances in Non–Small Cell Lung Cancer Research and Clinical Trials With Beth Sandy, MSN, CRNP

Aligning Treatment Goals and Value-Based Care in Newly Diagnosed Multiple Myeloma With Joseph Kalis, PharmD, BCOP, and Eric Cannon, PharmD, FAMCP

Subsequent Treatment After CAR T-Cell Therapy in Large B-Cell Lymphoma With Armin Ghobadi, MD

About

Resources

Subscribe

Get the latest updates delivered to your inbox!

Follow Us

Copyright © Oncology Data Advisor. All rights reserved.